Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy

• Status: Completed
• Trial end date: 2024-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to investigate the effect of alpha-lipoic acid on inflammatory markers and cardiac fibrosis markers in diabetic patients with Ischemic Cardiomyopathy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Damanhour University
• Treatments: Thioctic Acid

Criteria

Inclusion criteria:

• Type 2 diabetes with a history of CAD.

• LV ejection fraction (LVEF) ≤40%.

• Ischemic heart failure patients with NYHA grade II-IV.

Exclusion criteria:

• Type 1 diabetes.

• Severe CKD with GFR ≤ 15 ml/min/1.73m^2.

• Severe liver disease.

• Thyroid disorders.

• Acute febrile illness.

• Autoimmune disorders or connective tissue disorders.